Latest Updates

Launches new anti-epileptic drug Fycompa (perampanel) in India Eisai Pharmaceuticals, in order to cater to the Japanese market,…

The drug is intended to be used for treatment of moderate to severe plaque psoriasis.

The drug will be manufacture at the groups manufacturing facility at the Pharma SEZ in Ahmedabad

The granting of this patent would block other manufacturers in India from supplying this vaccine

The company's Aurangabad facility underwent inspection in April 2017 Lupin has received notification that the inspection carried…

The partnership will promote further collaborative research activities and training programs between India and IVI

It reduces the urge to smoke and in turn help people give up the habit of smoking

KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies

The company will be ready to supply current market requirement of IMS with spare capacity

New enhancements increase capability for rapidly developing and commercializing new probiotics with decreased time to market